Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Victoria Furer*, Christien Rondaan, Nancy Agmon-Levin, Sander van Assen, Marc Bijl, Meliha Crnkic Kapetanovic, Annette de Thurah, Ulf Mueller-Ladner, Daphna Paran, Karen Schreiber, Klaus Warnatz, Nico M. Wulffraat, Ori Elkayam

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    31 Citations (Scopus)
    10 Downloads (Pure)

    Abstract

    In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.

    Original languageEnglish
    Article number001594
    Number of pages10
    JournalBMJ Open
    Volume7
    Issue number1
    DOIs
    Publication statusPublished - Feb-2021

    Keywords

    • vaccination
    • COVID-19
    • autoimmune diseases
    • SYSTEMIC-LUPUS-ERYTHEMATOSUS
    • CLINICAL-COURSE
    • METHOTREXATE
    • ARTHRITIS
    • OUTCOMES
    • SERIES

    Cite this